Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for M8694L103 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Migdal Insurance & Financial Holdings Ltd.
13G
|
4.4% |
11/13/2025
Event 9/30/2025
|
|
| Migdal Insurance & Financial Holdings Ltd | 0% | ||
| Migdal Insurance Company Ltd. | 0% | ||
| Migdal Sal Domestic Equities | 4.4% | ||
| Migdal Mutual Funds Ltd. | 0% | ||
|
Moshe Arkin
13D/A
Amendment 5
|
61.8% |
4/30/2025
Event 4/28/2025
|
|
| Moshe Arkin | 61.8% | ||
| M. Arkin Dermatology Ltd. | 60.5% | ||
|
Migdal Insurance & Financial Holdings Ltd.
13G
|
5.3% |
2/13/2025
Event 12/31/2024
|
|
| Migdal Insurance & Financial Holdings Ltd | 0% | ||
| Migdal Insurance Company Ltd. | 0% | ||
| Migdal Sal Domestic Equities | 5.3% | ||
| Migdal Mutual Funds Ltd. | 0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 1 | 7.61 k | $564 k |
| 2026 Q1 | 1 | 7.61 k | $603 k |
| 2025 Q4 | 1 | 7.61 k | $321 k |
| 2025 Q3 | 1 | 7.61 k | $222 k |
| 2025 Q2 | 2 | 265 k | $1.96 M |
| 2025 Q1 | 23 | 5.30 M | $2.76 M |
| 2024 Q4 | 19 | 5.23 M | $4.86 M |
| 2024 Q3 | 22 | 5.39 M | $3.67 M |
| 2024 Q2 | 23 | 7.43 M | $6.61 M |
| 2024 Q1 | 25 | 7.79 M | $7.64 M |
| 2023 Q4 | 26 | 8.67 M | $9.94 M |
| 2023 Q3 | 22 | 10.8 M | $17.7 M |
| 2023 Q2 | 20 | 7.88 M | $23.6 M |
| 2023 Q1 | 17 | 8.06 M | $31.3 M |
| 2022 Q4 | 15 | 5.70 M | $26.0 M |
| 2022 Q3 | 14 | 5.80 M | $29.5 M |
| 2022 Q2 | 18 | 5.79 M | $23.7 M |
| 2022 Q1 | 19 | 5.81 M | $42.9 M |
| 2021 Q4 | 20 | 5.87 M | $43.5 M |
| 2021 Q3 | 19 | 5.87 M | $58.7 M |
| 2021 Q2 | 18 | 5.86 M | $72.6 M |
| 2021 Q1 | 21 | 5.77 M | $71.5 M |
| 2020 Q4 | 22 | 6.20 M | $60.7 M |
| 2020 Q3 | 22 | 6.30 M | $44.5 M |
| 2020 Q2 | 26 | 6.54 M | $57.3 M |
| 2020 Q1 | 25 | 6.43 M | $44.9 M |
| 2019 Q4 | 17 | 5.22 M | $89.3 M |
| 2019 Q3 | 17 | 5.12 M | $45.2 M |
| 2019 Q2 | 17 | 3.76 M | $33.9 M |
| 2019 Q1 | 18 | 3.86 M | $26.1 M |
| 2018 Q4 | 13 | 3.99 M | $24.2 M |
| 2018 Q3 | 18 | 3.86 M | $28.7 M |
| 2018 Q2 | 22 | 4.21 M | $33.2 M |
| 2018 Q1 | 20 | 4.22 M | $43.4 M |